Show simple item record

dc.contributor.authorHannan, Nicole
dc.contributor.authorMcMillan, Sara
dc.contributor.authorSteel, Amie
dc.contributor.authorTiralongo, Evelin
dc.date.accessioned2020-08-17T02:24:30Z
dc.date.available2020-08-17T02:24:30Z
dc.date.issued2019
dc.identifier.issn2212-9588
dc.identifier.doi10.1016/j.aimed.2019.03.058
dc.identifier.urihttp://hdl.handle.net/10072/396480
dc.description.abstractBackground: Eosinophilic Oesophagitis (EoE) is a rare inflammatory gastrointestinal disorder; high levels of eosinophils in the oesophagus result in oesophageal dysfunction and other gastrointestinal symptoms. The prevalence of paediatric EoE in Australia is estimated at 1 in 10,000. There is limited information about the use of complementary medicines (CMs) for paediatric EoE. Methods: A national cross-sectional online survey of Australian parents of children with EoE (up to 18 years of age) was conducted between September 2018 and February 2019. The survey explored the types of CMs being used for the treatment of paediatric EoE, as well as the reasons for their use and how they were recommended. Preliminary analysis has been conducted with descriptive statistics. Results: As of the end of January 2019, 209 participants completed the survey. Preliminary findings confirm that CM use is common, particularly probiotics (43.20%) and other nutritional supplements (42%), with a 55.9% increase in CM use post-diagnosis. Of the parents who sought conventional treatment for their child's EoE, 70.78% also sought CM. Although often self-prescribed 43.2% of parents expressed concerns with CM use, most notably CM effectiveness (87%), practitioner level of training (64.10%), and side effects (51.60%). Despite this, across all CM categories parents indicated that they would be most likely to continue CM use. Conclusion: This study outlines areas where additional support pathways for paediatric EoE families are needed. It increases practitioner awareness, highlights the need for training and collaboration between health professionals and can assist in designing safe evidence based CM treatment guidelines.
dc.languageen
dc.publisherElsevier BV
dc.relation.ispartofpagefromS21
dc.relation.ispartofissueSupplement 1
dc.relation.ispartofjournalAdvances in Integrative Medicine
dc.relation.ispartofvolume6
dc.subject.fieldofresearchComplementary and Alternative Medicine
dc.subject.fieldofresearchNutrition and Dietetics
dc.subject.fieldofresearchPublic Health and Health Services
dc.subject.fieldofresearchcode1104
dc.subject.fieldofresearchcode1111
dc.subject.fieldofresearchcode1117
dc.titleComplementary medicines, treatments and practices for paediatric eosinophilic oesophagitis: Findings from a cross-sectional survey of Australian parents
dc.typeJournal article
dc.type.descriptionC2 - Articles (Other)
dcterms.bibliographicCitationHannan, N; McMillan, S; Steel, A; Tiralongo, E, Complementary medicines, treatments and practices for paediatric eosinophilic oesophagitis: Findings from a cross-sectional survey of Australian parents, Advances in Integrative Medicine, 2019, 6 (Supplement 1), pp. S21-S21
dc.date.updated2020-08-17T02:14:02Z
gro.hasfulltextNo Full Text
gro.griffith.authorHannan, Nicole
gro.griffith.authorMcMillan, Sara S.
gro.griffith.authorTiralongo, Evelin


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record